Similar results were obtained from a murine tumor-bearing mice model in vivo, in which OVA-expressing lymphoma cell line E.G7 cells were transplanted and introduced antitumor responses by CD8+ T cells from OT-I TCR-Tg mice. This evidence concerns the gene CD8A and neoplasm.